Literature DB >> 21779681

A first case of protease codon 35 amino acid insertion in a HIV-1 subtype B sequence detected in the Bauru region, state of São Paulo, Brazil: case report.

Rejane Maria Tommasini Grotto1, Sílvia Maria Corvino, Lilian da Silva Reis Munhoz, Cibele Gomes Ghedini, Maria Inês de Moura Campos Pardini.   

Abstract

Amino acid insertions in the protease have rarely been described in HIV-infected patients. One of these insertions has recently been described in codon 35, although its impact on resistance remains unknown. This study presents a case of an HIV variant with an insertion in codon 35 of the protease, described for the first time in Bauru, State of Sao Paulo, Brazil, circulating in a 38-year-old caucasian male with asymptomatic HIV infection since 1997. The variant isolated showed a codon 35 insertion of two amino acids in the protease: a threonine and an aspartic acid, resulting in the amino acid sequence E35E_TD.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21779681     DOI: 10.1590/s0037-86822011000300027

Source DB:  PubMed          Journal:  Rev Soc Bras Med Trop        ISSN: 0037-8682            Impact factor:   1.581


  1 in total

1.  GS-8374, a prototype phosphonate-containing inhibitor of HIV-1 protease, effectively inhibits protease mutants with amino acid insertions.

Authors:  Klára Grantz Šašková; Milan Kozíšek; Kirsten Stray; Dorien de Jong; Pavlína Rezáová; Jirí Brynda; Noortje M van Maarseveen; Monique Nijhuis; Tomáš Cihlár; Jan Konvalinka
Journal:  J Virol       Date:  2013-12-26       Impact factor: 5.103

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.